Mitochondria
mitochondria
Astrocytes: From Metabolism to Cognition
Different brain cell types exhibit distinct metabolic signatures that link energy economy to cellular function. Astrocytes and neurons, for instance, diverge dramatically in their reliance on glycolysis versus oxidative phosphorylation, underscoring that metabolic fuel efficiency is not uniform across cell types. A key factor shaping this divergence is the structural organization of the mitochondrial respiratory chain into supercomplexes. Specifically, complexes I (CI) and III (CIII) form a CI–CIII supercomplex, but the degree of this assembly varies by cell type. In neurons, CI is predominantly integrated into supercomplexes, resulting in highly efficient mitochondrial respiration and minimal reactive oxygen species (ROS) generation. Conversely, in astrocytes, a larger fraction of CI remains unassembled, freely existing apart from CIII, leading to reduced respiratory efficiency and elevated mitochondrial ROS production. Despite this apparent inefficiency, astrocytes boast a highly adaptable metabolism capable of responding to diverse stressors. Their looser CI–CIII organization allows for flexible ROS signaling, which activates antioxidant programs via transcription factors like Nrf2. This modular architecture enables astrocytes not only to balance energy production but also to support neuronal health and influence complex organismal behaviors.
CNS Control of Peripheral Mitochondrial Form and Function: Mitokines
My laboratory has made an intriguing discovery that mitochondrial stress in one tissue can be communicated to distal tissues. We find that mitochondrial stress in the nervous system triggers the production of entities known as mitokines. These mitokines are discharged from the nervous system, orchestrating a response in peripheral tissues that extends the lifespan of C. elegans. The revelation came as a surprise, given the prevalent belief that cell autonomous mechanisms would underlie the relationship between mitochondrial function and aging. It was also surprising given the prevailing dogma that mitochondrial function must be increased, not decreased, to improve health and longevity. Our work also underscores the fact that mitochondria, which originated as a microbial entity and later evolved into an intracellular symbiont, have retained their capacity for intercommunication, now facilitated by signals from the nervous system. We hypothesize that this communication has evolved as a mechanism to reduce infection from pathogens.
Mitochondrial diversity in the mouse and human brain
The basis of the mind, of mental states, and complex behaviors is the flow of energy through microscopic and macroscopic brain structures. Energy flow through brain circuits is powered by thousands of mitochondria populating the inside of every neuron, glial, and other nucleated cell across the brain-body unit. This seminar will cover emerging approaches to study the mind-mitochondria connection and present early attempts to map the distribution and diversity of mitochondria across brain tissue. In rodents, I will present convergent multimodal evidence anchored in enzyme activities, gene expression, and animal behavior that distinct behaviorally-relevant mitochondrial phenotypes exist across large-scale mouse brain networks. Extending these findings to the human brain, I will present a developing systematic biochemical and molecular map of mitochondrial variation across cortical and subcortical brain structures, representing a foundation to understand the origin of complex energy patterns that give rise to the human mind.
‘Going South!’ Comparative mitochondrial biology in ageing and neurodegeneration
Mechanisms Underlying the Persistence of Cancer-Related Fatigue
Cancer-related fatigue is a prominent and debilitating side effect of cancer and its treatment. It can develop prior to diagnosis, generally peaks during cancer treatment, and can persist long after treatment completion. Its mechanisms are multifactorial, and its expression is highly variable. Unfortunately, treatment options are limited. Our research uses syngeneic murine models of cancer and cisplatin-based chemotherapy to better understand these mechanisms. Our data indicate that both peripherally and centrally processes may contribute to the developmental of fatigue. These processes include metabolic alterations, mitochondrial dysfunction, pre-cachexia, and inflammation. However, our data has revealed that behavioral fatigue can persist even after the toxicity associated with cancer and its treatment recover. For example, running during cancer treatment attenuates kidney toxicity while also delaying recovery from fatigue-like behavior. Additionally, administration of anesthetics known to disrupt memory consolidation at the time treatment can promote recovery, and treatment-related cues can re-instate fatigue after recovery. Cancer-related fatigue can also promote habitual behavioral patterns, as observed using a devaluation task. We interpret this data to suggest that limit metabolic resources during cancer promote the utilization of habit-based behavioral strategies that serve to maintain fatigue behavior into survivorship. This line of work is exciting as it points us toward novel interventional targets for the treatment of persistent cancer-related fatigue.
Redox and mitochondrial dysregulation in epilepsy
Epileptic seizures render the brain uniquely dependent on energy producing pathways. Studies in our laboratory have been focused on the role of redox processes and mitochondria in the context of abnormal neuronal excitability associated with epilepsy. We have shown that that status epilepticus (SE) alters mitochondrial and cellular redox status, energetics and function and conversely, that reactive oxygen species and resultant dysfunction can lead to chronic epilepsy. Oxidative stress and neuroinflammatory pathways have considerable crosstalk and targeting redox processes has recently been shown to control neuroinflammation and excitability. Understanding the role of metabolic and redox processes can enable the development of novel therapeutics to control epilepsy and/or its comorbidities.
Brain-muscle signaling coordinates exercise adaptations in Drosophila
Chronic exercise is a powerful intervention that lowers the incidence of most age-related diseases while promoting healthy metabolism in humans. However, illness, injury or age prevent many humans from consistently exercising. Thus, identification of molecular targets that can mimic the benefits of exercise would be a valuable tool to improve health outcomes of humans with neurodegenerative or mitochondrial diseases, or those with enforced sedentary lifestyles. Using a novel exercise platform for Drosophila, we have identified octopaminergic neurons as a key subset of neurons that are critical for the exercise response, and shown that periodic daily stimulation of these neurons can induce a systemic exercise response in sedentary flies. Octopamine is released into circulation where it signals through various octopamine receptors in target tissues and induces gene expression changes similar to exercise. In particular, we have identified several key molecules that respond to octopamine in skeletal muscle, including the mTOR modulator Sestrin, the PGC-1α homolog Spargel, and the FNDC5/Irisin homolog Iditarod. We are currently testing these molecules as potential therapies for multiple diseases that reduce mobility, including the PolyQ disease SCA2 and the mitochondrial disease Barth syndrome.
Mitochondria and Monoamines - Better Together
Mitochondrial leukodystrophies
Metabolic spikes: from rogue electrons to Parkinson's
Conventionally, neurons are thought to be cellular units that process synaptic inputs into synaptic spikes. However, it is well known that neurons can also spike spontaneously and display a rich repertoire of firing properties with no apparent functional relevance e.g. in in vitro cortical slice preparations. In this talk, I will propose a hypothesis according to which intrinsic excitability in neurons may be a survival mechanism to minimize toxic byproducts of the cell’s energy metabolism. In neurons, this toxicity can arise when mitochondrial ATP production stalls due to limited ADP. Under these conditions, electrons deviate from the electron transport chain to produce reactive oxygen species, disrupting many cellular processes and challenging cell survival. To mitigate this, neurons may engage in ADP-producing metabolic spikes. I will explore the validity of this hypothesis using computational models that illustrate the implications of synaptic and metabolic spiking, especially in the context of substantia nigra pars compacta dopaminergic neurons and their degeneration in Parkinson's disease.
Pathogenesis of Parkison's Disease
Parp mutations protect from mitochondrial toxicity in Alzheimer’s disease
Alzheimer’s disease is the most common age-related neurodegenerative disorder. Familial forms of Alzheimer’s disease associated with the accumulation of a toxic form of amyloid-β (Aβ) peptides are linked to mitochondrial impairment. The coenzyme nicotinamide adenine dinucleotide (NAD+) is essential for both mitochondrial bioenergetics and nuclear DNA repair through NAD+-consuming poly (ADP-ribose) polymerases (PARPs). Here, we analysed the metabolomic changes in flies over-expressing Aβ and showed a decrease of metabolites associated with nicotinate and nicotinamide metabolism, which is critical for mitochondrial function in neurons. We show that increasing the bioavailability of NAD+ protects against Aβ toxicity. Pharmacological supplementation using NAM, a form of vitamin B that acts as a precursor for NAD+ or a genetic mutation of PARP rescues mitochondrial defects, protects neurons against degeneration and reduces behavioural impairments in a fly model of Alzheimer’s disease. Next, we looked at links between PARP polymorphisms and vitamin B intake in patients with Alzheimer’s disease. We show that polymorphisms in the human PARP1 gene or the intake of vitamin B, are associated with a decrease in the risk and severity of Alzheimer’s disease. We suggest that enhancing the availability of NAD+ by either vitamin B supplements or the inhibition of NAD+-dependent enzymes, such as PARPs are potential therapies for Alzheimer’s disease.
Firing Rate Homeostasis in Neural Circuits: From basic principles to malfunctions
Maintaining average activity level within a set-point range constitutes a fundamental property of central neural circuits. Accumulated evidence suggests that firing rate distributions and their means represent physiological variables regulated by homeostatic systems during sleep-wake cycle in central neural circuits. While intracellular Ca2+ has long been hypothesized as a feedback control signal, the source of Ca2+ and the molecular machinery enabling network-wide homeostatic responses remain largely unknown. I will present our hypothesis and framework on identifying homeostatic regulators in neural circuits. Next, I will show our new results on the role of mitochondria in the regulation of activity set-points and feedback responses. Finally, I will provide an evidence on state-dependent dysregulation of activity set-points at the presymptomatic disease stage in familial Alzheimer’s models.
Mitochondrial mechanisms in psychostimulant and opioid action
Gene therapy in neuromuscular and mitochondrial disorders
Firing Homeostasis in Neural Circuits: From Basic Principles to Malfunctions
Neural circuit functions are stabilized by homeostatic mechanisms at long timescales in response to changes in experience and learning. However, we still do not know which specific physiological variables are being stabilized, nor which cellular or neural-network components comprise the homeostatic machinery. At this point, most evidence suggests that the distribution of firing rates amongst neurons in a brain circuit is the key variable that is maintained around a circuit-specific set-point value in a process called firing rate homeostasis. Here, I will discuss our recent findings that implicate mitochondria as a central player in mediating firing rate homeostasis and its impairments. While mitochondria are known to regulate neuronal variables such as synaptic vesicle release or intracellular calcium concentration, we searched for the mitochondrial signaling pathways that are essential for homeostatic regulation of firing rates. We utilize basic concepts of control theory to build a framework for classifying possible components of the homeostatic machinery in neural networks. This framework may facilitate the identification of new homeostatic pathways whose malfunctions drive instability of neural circuits in distinct brain disorders.
Novel mechanisms of neurogenesis and neural repair
In order to re-install neurogenesis after loss of neurons upon injury or neurodegeneration, we need to understand the basic principles of neurogenesis. I will first discuss about our discovery of a novel centrosome protein (Camargo et al., 2019) and discuss unpublished work about the great diversity of interphase centrosome proteomes and their relevance for neurodevelopmental disorders. I would then present work on a master regulator of neural stem cell amplification and brain folding (Stahl et al., 2013; Esgleas et al., 2020) to proceed presenting data on utilizing some of these factors for turning astrocytes into neurons. I will present data on the critical role of mitochondria in this conversion process (Gascon et al., 2016, Russo et al., 2020) and how it regulates the speed of conversion also showing unpublished data. If time permits I may touch on recent progress in in vivo reprogramming (Mattugini et al., 2019). Taken together, these data highlight the surprising specificity and importance of organelle diversity from centrosome, nucleolus and mitochondria as key regulators in development and reprogramming.
Phospholipid regulation in cognitive impairment and vascular dementia
An imbalance in lipid metabolism in neurodegeneration is still poorly understood. Phospholipids (PLs) have multifactorial participation in vascular dementia as Alzheimer, post-stroke dementia, CADASIL between others. Which include the hyperactivation of phospholipases, mitochondrial stress, peroxisomal dysfunction and irregular fatty acid composition triggering proinflammation in a very early stage of cognitive impairment. The reestablishment of physiological conditions of cholesterol, sphingolipids, phospholipids and others are an interesting therapeutic target to reduce the progression of AD. We propose the positive effect of BACE1 silencing produces a balance of phospholipid profile in desaturase enzymes-depending mode to reduce the inflammation response, and recover the cognitive function in an Alzheimer´s animal and brain stroke models. Pointing out there is a great need for new well-designed research focused in preventing phospholipids imbalance, and their consequent energy metabolism impairment, pro-inflammation and enzymatic over-processing, which would help to prevent unhealthy aging and AD progression.
Beyond energy - an unconventional role of mitochondria in cone photoreceptors
The long-term goal of my research is to study the mammalian retina as a model for the central nervous system (CNS) -- to understand how it functions in physiological conditions, how it is formed, how it breaks down in pathological conditions, and how it can be repaired. I have focused on two research themes: 1) Photoreceptor structure, synapse, circuits, and development, 2) Hibernation and metabolic adaptations in the retina and beyond. As the first neuron of the visual system, photoreceptors are vital for photoreception and transmission of visual signals. I am particularly interested in cone photoreceptors, as they mediate our daylight vision with high resolution color information. Diseases affecting cone photoreceptors compromise visual functions in the central macular area of the human retina and are thus most detrimental to our vision. However, because cones are much less abundant compared to rods in most mammals, they are less well studied. We have used the ground squirrel (GS) as a model system to study cone vision, taking advantage of their unique cone-dominant retina. In particular, we have focused on short-wavelength sensitive cones (S-cones), which are not only essential for color vision, but are also an important origin of signals for biological rhythm, mood and cognitive functions, and the growth of the eye during development. We are studying critical cone synaptic structures – synaptic ribbons, the synaptic connections of S-cones, and the development of S-cones with regard to their specific connections. These works will provide knowledge of normal retinal development and function, which can also be extended to the rest of CNS; for example, the mechanisms of synaptic targeting during development. In addition, such knowledge will benefit the development of optimal therapeutic strategies for regeneration and repair in cases of retinal degenerative disease. Many neurodegenerative diseases, including retinal diseases, are rooted in metabolic stress in neurons and/or glial cells. Using the same GS model, we aim to learn from this hibernating mammal, which possesses an amazing capability to adapt to the extreme metabolic conditions during hibernation. By exploring the mechanisms of such adaptation, we hope to discover novel therapeutic tactics for neurodegenerative diseases.
Mitochondrial vesicle transport and the stress response in Parkinsons models
A journey through connectomics: from manual tracing to the first fully automated basal ganglia connectomes
The "mind of the worm", the first electron microscopy-based connectome of C. elegans, was an early sign of where connectomics is headed, followed by a long time of little progress in a field held back by the immense manual effort required for data acquisition and analysis. This changed over the last few years with several technological breakthroughs, which allowed increases in data set sizes by several orders of magnitude. Brain tissue can now be imaged in 3D up to a millimeter in size at nanometer resolution, revealing tissue features from synapses to the mitochondria of all contained cells. These breakthroughs in acquisition technology were paralleled by a revolution in deep-learning segmentation techniques, that equally reduced manual analysis times by several orders of magnitude, to the point where fully automated reconstructions are becoming useful. Taken together, this gives neuroscientists now access to the first wiring diagrams of thousands of automatically reconstructed neurons connected by millions of synapses, just one line of program code away. In this talk, I will cover these developments by describing the past few years' technological breakthroughs and discuss remaining challenges. Finally, I will show the potential of automated connectomics for neuroscience by demonstrating how hypotheses in reinforcement learning can now be tackled through virtual experiments in synaptic wiring diagrams of the songbird basal ganglia.
On the purpose and origin of spontaneous neural activity
Spontaneous firing, observed in many neurons, is often attributed to ion channel or network level noise. Cortical cells during slow wave sleep exhibit transitions between so called Up and Down states. In this sleep state, with limited sensory stimuli, neurons fire in the Up state. Spontaneous firing is also observed in slices of cholinergic interneurons, cerebellar Purkinje cells and even brainstem inspiratory neurons. In such in vitro preparations, where the functional relevance is long lost, neurons continue to display a rich repertoire of firing properties. It is perplexing that these neurons, instead of saving their energy during information downtime and functional irrelevance, are eager to fire. We propose that spontaneous firing is not a chance event but instead, a vital activity for the well-being of a neuron. We postulate that neurons, in anticipation of synaptic inputs, keep their ATP levels at maximum. As recovery from inputs requires most of the energy resources, neurons are ATP surplus and ADP scarce during synaptic quiescence. With ADP as the rate-limiting step, ATP production stalls in the mitochondria when ADP is low. This leads to toxic Reactive Oxygen Species (ROS) formation, which are known to disrupt many cellular processes. We hypothesize that spontaneous firing occurs at these conditions - as a release valve to spend energy and to restore ATP production, shielding the neuron against ROS. By linking a mitochondrial metabolism model to a conductance-based neuron model, we show that spontaneous firing depends on baseline ATP usage and on ATP-cost-per-spike. From our model, emerges a mitochondrial mediated homeostatic mechanism that provides a recipe for different firing patterns. Our findings, though mostly affecting intracellular dynamics, may have large knock-on effects on the nature of neural coding. Hitherto it has been thought that the neural code is optimised for energy minimisation, but this may be true only when neurons do not experience synaptic quiescence.
Biophysics of Mitochondrial Metabolism in vivo
Aged microglia in Alzheimer’s disease display a senescent and pro-inflammatory profile associated with mitochondrial oxidative stress
FENS Forum 2024
Aging impairs mitochondrial metabolism and causes atrophy of human cortical astrocytes
FENS Forum 2024
BDNF-induced synaptic plasticity: The role of mitochondrial fission
FENS Forum 2024
The bright side of mitochondrial calcium uniporter: MCU can protect hippocampal CA2 neurons from excitotoxic damage
FENS Forum 2024
Changes in mitochondrial respiration and mitochondrial dynamics induced by mitochondrial complex I inhibition in primary cortical neurons: Association with schizophrenia-like phenotype
FENS Forum 2024
The mitochondria-targeted antioxidant AntiOxCIN4 mitigates cardiac oxidative/nitrosative stress in the amyotrophic lateral sclerosis SOD1G93A mouse
FENS Forum 2024
Cocaine detrimentally affects mitochondrial functionality and cell viability in dopaminergic neurons
FENS Forum 2024
Contribution of cGAS-P2X2 crosstalk on synaptic failure and mitochondrial dysfunction induced by β-amyloid oligomers
FENS Forum 2024
The crosstalk between the epigenome and mitochondria as central player in neural fate decisions of the axotomized neurons after spinal cord injury
FENS Forum 2024
A deep sequencing investigation of mitochondrial DNA damage in cholinergic neurons of the Pedunculopontine Nucleus
FENS Forum 2024
Dendritic mitochondrial transport in mature neurons is important for motor skill learning
FENS Forum 2024
Doublecortin mutation leads to alterations in mitochondria during hippocampal development
FENS Forum 2024
Dysregulation of FLVCR1-dependent mitochondrial calcium handling in neural stem cells causes congenital hydrocephalus
FENS Forum 2024
Early hippocampal hyperexcitability and mitochondrial changes in a transgenic mouse model of dementia with Lewy bodies
FENS Forum 2024
Effect of alpha-synuclein on the expression of genes encoded in mitochondrial DNA
FENS Forum 2024
The effect of second-generation antipsychotics on mitochondria and the development of metabolic syndrome
FENS Forum 2024
Exploring the impact of transglutaminase 2 in Parkinson’s disease: Mitochondrial dysfunction and proteomic pathways
FENS Forum 2024
From systems biology to drug targets: ATP synthase subunit upregulation causes mitochondrial dysfunction in Shank3Δ4-22 mouse model of autism
FENS Forum 2024
Hyperglycemia affects mitochondrial respiratory chain but not the hydrogen peroxide production in neurons during ischemic stroke
FENS Forum 2024
Investigating mitochondrial stress signalling in single neurons
FENS Forum 2024
Interactions between amyloid beta 1-42 and nuclear transcription factors in mitochondria
FENS Forum 2024
The interplay between oxidative stress, mitochondrial dysfunction, and alteration of parvalbumin interneurons in postmortem brain of Alzheimer’s disease and mild cognitive impairment patients
FENS Forum 2024
Investigating the acute impact of sweeteners sucralose and Ace-K on ATP production and mitochondrial respiration in the hypothalamic GT1-7 cell line challenged with increased glucose
FENS Forum 2024
Investigating the AMPK-MFF pathway to modulate mitochondrial dynamics as a target for neuroprotection
FENS Forum 2024
Investigating the efficiency of a mitochondria booster to improve anxiety-related behaviors: Accumbal metabolic and neurobiological mechanisms
FENS Forum 2024
Investigating the role of mitochondrial regulator Zc3h10 on neuronal function
FENS Forum 2024
Investigating the role of Rab proteins in mitochondrial dysfunction related to Parkinson’s disease
FENS Forum 2024
Microglia mitochondrial complex I deficiency during development induces glial dysfunction and early lethality
FENS Forum 2024
Mitochondrial dysfunction and Purkinje cell loss in Christianson syndrome
FENS Forum 2024
Are mitochondria a missing link between arginase 2 loss and Huntington’s disease pathogenesis?
FENS Forum 2024
Mitochondrial dysfunction underlies impaired neurovascular coupling following traumatic brain injury
FENS Forum 2024
Mitochondrial fission regulates reactive astrocyte response to acute brain injury
FENS Forum 2024
Mitochondrial origins of sleep pressure control
FENS Forum 2024
Mitochondrial pyruvate metabolism regulates the activation of quiescent adult neural stem cells
FENS Forum 2024
MPC2 variants disrupt mitochondrial pyruvate metabolism and cause an early-onset mitochondriopathy
FENS Forum 2024
Multi-omics approach identified a network of lipids and proteins associated with lysosomal and mitochondrial metabolism in Parkinson’s disease patients carrying mutations in TMEM175 gene
FENS Forum 2024
Neuronal activity inhibits axonal mitochondrial transport in a region-specific manner
FENS Forum 2024
Normalization of the accumbal cell type-specific transcriptomic signatures and anxiety-like behaviour following treatment with a mitochondrial booster in outbred rats
FENS Forum 2024
A novel perspective: Early-life stress at the origin of AD-related mitochondrial dysfunctions
FENS Forum 2024
Optogenetically de-energized mitochondria of parvalbumin-positive interneurons impair spatial properties within the CA1 region of the hippocampus
FENS Forum 2024